On the other hand, A20/TNFAIP3 and TNIP1 which terminate NF-κB signaling [37] were also significantly upregulated in c-Rel+ GCB-DLBCL (Fig. 3E, Supplementary Fig. S3K). The gene discussed is REL; the disease is diffuse large B-cell lymphoma.